The former is also a vector for yellow fever.3 The pharmaceutical industry is likely to benefit from climate change as increasing temperatures are expected to result in a rise in the number of diseases spread by vectors, such as mosquitoes and fleas, thereby increasing demand for vaccines, according to a report from Morgan Stanley. “Climate change will be good news for pharmaceuticals,” said Michael J. Nelson, an analyst at Morgan Stanley, who wrote the report. The report estimated that $50bn to $125bn of vaccines will be needed to cover the extra exposure, with Sanofi and GlaxoSmithKline set to benefit the most due to their pipelines for tropical disease drugs.
The pharmaceutical industry is likely to benefit from climate change as increasing temperatures are expected to result in a rise in the number of diseases spread by vectors, such as mosquitoes and fleas, thereby increasing demand for vaccines, according to a report from Morgan Stanley. “Climate change will be good news for pharmaceuticals,” said Michael J. Nelson, an analyst at Morgan Stanley, who wrote the report. The report estimated that $50bn to $125bn of vaccines will be needed to cover the extra exposure, with Sanofi and GlaxoSmithKline set to benefit the most due to their pipelines for tropical disease drugs.